Experimental Insulin-like Growth Factor Receptor Inhibitor Reduced Pancreatic Cancer Growth
Tuesday, April 14, 2009 - 18:35
in Health & Medicine
Researchers are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a new article.